We found decreased levels of NLRP6 and its main effector IL-18 in the jejunum from patients with T2D, suggesting a defective sensor system to detect PAMPS and DAMPS that drives to a damaged epithelial barrier that increases intestinal permeability and allows leakage of bacteria or bacterial products. Here, NLRP6 is linked to type 2 diabetes mellitus.